Beacon Biosignals

Beacon Biosignals builds an AI platform and FDA-cleared at-home EEG wearables used by biopharma and clinicians to develop and deliver treatments for neurological, psychiatric, and sleep disorders. It sells clinical development services and software for brain-signal analysis to life sciences partners, and operates a diagnostics business providing reimbursable EEG and cardiopulmonary assessments. Founded in 2019 and headquartered in Boston, the company is privately held.